|Croatian citizens show support for Chinese investments|
|6th March 2018|
|ZAGREB - Even 86 percent of Croatian citizens back Chinese investments in Croatia. The research was conducted by the GfK agency, led by research director Tatjana Rajković and her associate Tamara Kraus. Thousand respondents selected by the representative sample method answered the questions.|
86 percent of respondents reported that investments in infrastructure facilities, such as bridges and wind farms, and 84 percent in the construction of highways, railway lines or more precisely, 71 percent believe that the biggest potential has Chinese investment in infrastructure, 66 percent in tourism, 37 percent in E-commerce ... Research results have also shown that more than women support Chinese investments and that Dalmatian citizens, more than others, consider tourism as the potentially the best investment area for Chinese capital.
Such great support for the entry of Chinese capital into Croatia is particularly important these days when a definitive decision of the Croatian government is expected on who will build Pelješac Bridge.
The research also showed that Croatian citizens have a very positive relationship with China. So, on the question of whether relations between China and Croatia are friendly, 89 percent of those surveyed said they were friendly, of which 74 percent thought they were very friendly and 15 percent friendly. Respondents also estimated that China showed a greater interest in investing in Croatia than Croatian politicians. The interest of the Chinese investment companies in Croatia was rated at 5.1, out of the possible 7, while the interest of the Croatians for investment in China was rated 4.3.
Even 50 percent of respondents believe that bureaucracy in Croatia is the main culprit for lack of Chinese investments, 16 percent say government responsibility, 14 percent decides on the EU rather than Croatia, while six percent think the last word is US. At the same time, 85 percent of respondents experience China as a trusted partner.
|31st March 2021|
|WHO: Sinopharm, Sinovac COVID-19 vaccine data show efficacy|